GSK plc (GSK) Form 6-K — Oct 13, 2026
GSK plc filed a Form 6-K on October 13, 2026 containing routine PDMR transaction notifications for executives including CEO Luke Miels, CFO Julie Brown, and other senior leaders. The filings are mandated disclosures under UK/EU market abuse rules, not discretionary announcements. Most transactions were small automatic acquisitions of ordinary shares at £17.5852-£17.6650 on October 8-9, 2026, driven by dividend reinvestment on the October 8, 2026 dividend payment and purchases under GSK's Share Reward Plan on the London Stock Exchange. One entry notes President US Maya Martinez-Davis acquired 10.155 notional ADS at $47.02 within her executive savings plan on the NYSE.
Key figures
- Total notified executives
- 12
- Share reward plan price gbp
- 17.6539
- Dividend reinvestment price gbp
- 17.5852
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.